Whereas, neither CD4+CD25+Foxp3+Helios+ nor CCR6+ response to α-glucosidase inhibitors was observed in the groups when treatment started at arthritis induction (Figures 3C, D). This evidence concerns the gene FOXP3 and arthritic joint disease.